Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;29(5):2363-2373.
doi: 10.1007/s00520-020-05753-x. Epub 2020 Sep 12.

Distinct diarrhea profiles during outpatient chemotherapy

Rafael Diaz  1 , Kord M Kober  1 , Carol Viele  1 , Bruce A Cooper  1 , Steven M Paul  1 , Marilyn Hammer  2 , Fay Wright  3 , Yvette P Conley  4 , Jon D Levine  5 , Christine Miaskowski  6   7
Affiliations
Free article

Distinct diarrhea profiles during outpatient chemotherapy

Rafael Diaz et al. Support Care Cancer. 2021 May.
Free article

Abstract

Purpose: Chemotherapy-induced diarrhea (CID) is a common symptom that occurs in 50 to 80% of patients. Given that the majority of the data on the occurrence and severity of CID is based on physician-rated toxicity criteria, this study's purposes were to identify subgroups of patients with distinct CID profiles and determine how these subgroups differ in terms of demographic and clinical characteristics; severity, frequency, and distress of CID; the co-occurrence of common GI symptoms; and QOL.

Methods: Patients (n = 1133) completed the Memorial Symptom Assessment Scale six times over two cycles of chemotherapy. Latent profile analysis was used to identify subgroups of patients with distinct diarrhea profiles. Differences among these subgroups were evaluated using parametric and nonparametric statistics.

Results: Four distinct diarrhea profiles were identified: none (58.3%), decreasing (22.0%), increasing (5.2%), and high (14.5%). Compared with the none class, patients in the high class had a lower functional status, a worse comorbidity profile, were more likely to have gastrointestinal cancer, and were more likely to receive chemotherapy on a 14-day cycle. No differences were found among the classes in the percentages of patients who received chemotherapy with a targeted therapy.

Conclusion: Given that CID occurred in over 40% of the patients, clinicians should assess for this symptom and other common GI symptoms and initiate appropriate pharmacologic and dietary interventions.

Keywords: Cancer; Chemotherapy; Diarrhea; Latent class analysis; Quality of life.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, Wedlake L, Bridgewater J, Glynne-Jones R, Allum W, Chau I, Wilson R, Ferry D (2014) Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol 15:e447–e460 - DOI
    1. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: the alcohol use disorders identification test: guidelines for use in primary care. In: AUDIT: the alcohol use disorders identification test: guidelines for use in primary care. World Health Organization, Geneva, Switzerland
    1. Bossi P, Antonuzzo A, Cherny NI, Rosengarten O, Pernot S, Trippa F, Schuler U, Snegovoy A, Jordan K, Ripamonti CI (2018) Diarrhoea in adult cancer patients: ESMO clinical practice guidelines. Ann Oncol 29(Suppl 4):iv126–iv142 - DOI
    1. Cascinu S, Barni S, Labianca R, Del Ferro E, Rocchi MB, Ligi M, Pessi MA, Cazzaniga M, Zamparelli G, Ardizzoia A, Ugolini G, Ghiandoni G, Luporini G, Catalano G (1997) Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study. Support Care Cancer 5:314–317 - DOI
    1. Doong SH, Dhruva A, Dunn LB, West C, Paul SM, Cooper BA, Elboim C, Abrams G, Merriman JD, Langford DJ, Leutwyler H, Baggott C, Kober K, Aouizerat BE, Miaskowski C (2015) Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs 17:237–247 - DOI